Curaleaf Holdings (TSX: CURA) is going over the heads of Aurora Cannabis’ (TSX: ACB) board. The company said it intends to launch a formal takeover bid for Aurora, offering US$4.00 per share in cash and stock to fold the Canadian medical producer into what Curaleaf bills as the cannabis industry’s first global platform. Each Aurora share would be exchanged for 0.3463 Curaleaf subordinate voting shares plus US$0.75 in cash. Aurora shareholders would pick up exposure to a US$32 billion U.S. cannabis market that Curaleaf argues is finally seeing regulatory tailwinds. “We believe this combination represents a win-win for Curaleaf and Aurora shareholders,” said Boris Jordan, chairman and chief executive officer.